40 related articles for article (PubMed ID: 12100165)
1. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes.
Morikawa K; Morikawa S; Nakamura M; Miyawaki T
Br J Haematol; 2002 Jul; 118(1):296-304. PubMed ID: 12100165
[TBL] [Abstract][Full Text] [Related]
2. G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon Cancer.
Ray AL; Saunders AS; Nofchissey RA; Reidy MA; Kamal M; Lerner MR; Fung KM; Lang ML; Hanson JA; Guo S; Urdaneta-Perez MG; Lewis SE; Cloyde M; Morris KT
Clin Cancer Res; 2023 Jun; 29(11):2158-2169. PubMed ID: 36951682
[TBL] [Abstract][Full Text] [Related]
3. Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia.
Matsumura R; Mochizuki S; Morishita Y; Hayakawa H; Karakawa S; Kawaguchi H; Okada S; Hyakuna N; Kobayashi M
Hematol Rep; 2024 Feb; 16(1):98-105. PubMed ID: 38534880
[TBL] [Abstract][Full Text] [Related]
4. G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.
Karagiannidis I; Salataj E; Said Abu Egal E; Beswick EJ
Cytokine; 2021 Jun; 142():155479. PubMed ID: 33677228
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.
Trottier AM; Druhan LJ; Kraft IL; Lance A; Feurstein S; Helgeson M; Segal JP; Das S; Avalos BR; Godley LA
Blood Adv; 2020 Oct; 4(20):5269-5284. PubMed ID: 33108454
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim.
Kang KW; Lee BH; Jeon MJ; Yu ES; Kim DS; Lee SR; Sung HJ; Choi CW; Park Y; Kim BS
Cancer Med; 2020 Sep; 9(17):6102-6110. PubMed ID: 32633471
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury.
Liska MG; Dela Peña I
Brain Circ; 2017; 3(3):143-151. PubMed ID: 30276316
[TBL] [Abstract][Full Text] [Related]
8. Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus.
Sivakumar R; Abboud G; Mathews CE; Atkinson MA; Morel L
Front Immunol; 2018; 9():1053. PubMed ID: 29868014
[TBL] [Abstract][Full Text] [Related]
9. G-CSF inhibits LFA-1-mediated CD4
Zhao S; Gu Z; Wang L; Guan L; Wang F; Yang N; Luo L; Gao Z; Song Y; Wang L; Liu D; Gao C
Oncotarget; 2017 Aug; 8(31):51578-51590. PubMed ID: 28881670
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of G-CSF administration in microglia-mediated reactive T cell activation in vitro.
Peng W
Immunol Res; 2017 Aug; 65(4):888-902. PubMed ID: 28646409
[TBL] [Abstract][Full Text] [Related]
11. Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8
Salem ML; Nassef M; Abdel Salam SG; Zidan A; Mahmoud MH; Badr G; Rubinstein M; Cole D
J Immunotoxicol; 2016 Nov; 13(6):784-792. PubMed ID: 27417188
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of relapsed and refractory acute lymphocytic leukemia by modified CAG regimen].
Huang H; Liu L; Liu Y; Lin Q; Zhang Q; Yu F; Song Y; Fang B
Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):340-2. PubMed ID: 27094001
[No Abstract] [Full Text] [Related]
13. Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.
Bunse CE; Tischer S; Lahrberg J; Oelke M; Figueiredo C; Blasczyk R; Eiz-Vesper B
Clin Exp Immunol; 2016 Jul; 185(1):107-18. PubMed ID: 26990855
[TBL] [Abstract][Full Text] [Related]
14. Are there any new insights for G-CSF and/or AMD3100 in chemotherapy of haematological malignants?
Shen ZH; Zeng DF; Ma YY; Zhang X; Zhang C; Kong PY
Med Oncol; 2015 Dec; 32(12):262. PubMed ID: 26526720
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.
Xuan L; Wu X; Zhang Y; Fan Z; Ling Y; Huang F; Zhang F; Zhai X; Liu Q
J Transl Med; 2011 Dec; 9():215. PubMed ID: 22171570
[TBL] [Abstract][Full Text] [Related]
16. Inference of surface membrane factors of HIV-1 infection through functional interaction networks.
Jaeger S; Ertaylan G; van Dijk D; Leser U; Sloot P
PLoS One; 2010 Oct; 5(10):e13139. PubMed ID: 20967291
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells.
Rossetti M; Gregori S; Roncarolo MG
Eur J Immunol; 2010 Nov; 40(11):3097-106. PubMed ID: 20957751
[TBL] [Abstract][Full Text] [Related]
18. Growth factors in ischemic stroke.
Lanfranconi S; Locatelli F; Corti S; Candelise L; Comi GP; Baron PL; Strazzer S; Bresolin N; Bersano A
J Cell Mol Med; 2011 Aug; 15(8):1645-87. PubMed ID: 20015202
[TBL] [Abstract][Full Text] [Related]
19. Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection.
Xiao BG; Lu CZ; Link H
J Cell Mol Med; 2007; 11(6):1272-90. PubMed ID: 18205701
[TBL] [Abstract][Full Text] [Related]
20. Expression of granulocyte colony stimulating factor receptor in human colorectal cancer.
Yang X; Liu F; Xu Z; Chen C; Wu X; Li G; Li J
Postgrad Med J; 2005 May; 81(955):333-7. PubMed ID: 15879049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
